Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Auxilium Pharmaceuticals Inc (AUXL) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Auxilium Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1182129.
Total stock buying since 2014: $0.
Total stock sales since 2014: $34,786,431.
Total stock option exercises since 2014: $18,476,696.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2014 | 0 | $0 | 1,035,447 | $34,786,431 | 952,724 | $18,476,696 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2014-12 | 0 | $0 | 499,254 | $16,905,025 | 460,000 | $8,504,780 |
| 2014-11 | 0 | $0 | 536,193 | $17,881,406 | 492,724 | $9,971,916 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-12-05 | Lurker Nancy (Director) | Sale | 32,430 | 34.00 | 1,102,620 |
| 2014-12-05 | Lurker Nancy (Director) | Option Ex | 25,000 | 19.59 | 489,750 |
| 2014-12-05 | Adams Adrian (CEO and President) | Sale | 40,000 | 33.97 | 1,358,720 |
| 2014-12-05 | Adams Adrian (CEO and President) | Option Ex | 40,000 | 17.40 | 696,000 |
| 2014-12-05 | Mckee William (Director) | Sale | 18,000 | 34.00 | 612,000 |
| 2014-12-05 | Mckee William (Director) | Option Ex | 15,000 | 30.61 | 459,150 |
| 2014-12-05 | Friedman Paul A (Director) | Sale | 9,689 | 33.85 | 327,953 |
| 2014-12-04 | Friedman Paul A (Director) | Sale | 20,000 | 33.67 | 673,460 |
| 2014-12-04 | Friedman Paul A (Director) | Option Ex | 20,000 | 17.07 | 341,500 |
| 2014-12-03 | Fetzer Oliver (Director) | Sale | 50,000 | 34.00 | 1,700,000 |
| 2014-12-03 | Fetzer Oliver (Director) | Option Ex | 50,000 | 22.90 | 1,144,800 |
| 2014-12-02 | Fetzer Oliver (Director) | Sale | 50,000 | 34.03 | 1,701,650 |
| 2014-12-02 | Fetzer Oliver (Director) | Option Ex | 50,000 | 14.22 | 711,000 |
| 2014-12-02 | Classon Rolf A (Director) | Sale | 279,135 | 33.78 | 9,428,622 |
| 2014-12-02 | Classon Rolf A (Director) | Option Ex | 260,000 | 17.93 | 4,662,580 |
| 2014-11-25 | Jobes Elizabeth Varki (Chief Compliance Officer) | Sale | 27,802 | 34.04 | 946,407 |
| 2014-11-25 | Jobes Elizabeth Varki (Chief Compliance Officer) | Option Ex | 23,750 | 17.99 | 427,262 |
| 2014-11-25 | Tursi James Patrick (Chief Medical Officer) | Sale | 13,713 | 34.12 | 467,942 |
| 2014-11-25 | Tursi James Patrick (Chief Medical Officer) | Option Ex | 10,562 | 20.17 | 213,035 |
| 2014-11-21 | Armstrong Jennifer Lou (Senior Vice President, HR) | Sale | 75,803 | 33.50 | 2,539,097 |
| 2014-11-21 | Armstrong Jennifer Lou (Senior Vice President, HR) | Option Ex | 69,412 | 22.84 | 1,585,161 |
| 2014-11-21 | Tursi James Patrick (Chief Medical Officer) | Sale | 8,648 | 33.47 | 289,413 |
| 2014-11-21 | Tursi James Patrick (Chief Medical Officer) | Option Ex | 5,000 | 22.04 | 110,200 |
| 2014-11-21 | Koven Andrew I (EVP, CAO, GC and Secretary) | Sale | 139,683 | 33.44 | 4,670,720 |
| 2014-11-21 | Koven Andrew I (EVP, CAO, GC and Secretary) | Option Ex | 134,375 | 19.18 | 2,577,984 |
| 2014-11-20 | Tursi James Patrick (Chief Medical Officer) | Sale | 66,000 | 33.06 | 2,181,960 |
| 2014-11-20 | Tursi James Patrick (Chief Medical Officer) | Option Ex | 66,000 | 16.80 | 1,109,130 |
| 2014-11-20 | Wills Alan (EVP, Corporate Development) | Sale | 156,592 | 33.18 | 5,195,252 |
| 2014-11-20 | Wills Alan (EVP, Corporate Development) | Option Ex | 142,875 | 21.44 | 3,062,954 |
| 2014-11-20 | Glickman Mark A (EVP - Sales and Marketing) | Sale | 47,952 | 33.17 | 1,590,615 |
| 2014-11-20 | Glickman Mark A (EVP - Sales and Marketing) | Option Ex | 40,750 | 21.75 | 886,190 |
Insider trading activities including stock purchases, stock sales, and option exercises of AUXL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Auxilium Pharmaceuticals Inc (symbol AUXL, CIK number 1182129) see the Securities and Exchange Commission (SEC) website.